Recent Company News

• 03:05 AM ET Jun 30, 2025
  

  SAWAI GROUP HOLDINGS completes acquisition of FrontAct (¥1833.0000, 0)

• 10:55 PM ET Jun 04, 2025
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 11:53 AM ET Jun 12, 2025
  

  FDA granted Fast Track Designation to Sumitomo Pharma's nuvisertib for the treatment of myelofibrosis (¥1035.0000, 0)

• 12:00 AM ET Jun 12, 2025
  

  Sumitomo Pharma trading sharply higher +17%; brokers expressing optimism about FY3/26 profit outlook (¥1035.0000, +150)

• 08:48 PM ET Jun 11, 2025
  

  Sumitomo Pharma trading higher, upgraded to outperform from neutral at Daiwa (¥1035.0000, +150)

• 06:47 AM ET Jun 05, 2025
  

  Knight Therapeutics and Sumitomo Pharma enter into exclusive licensing agreements to commercialize Sumitomo's Canadian portfolio (C$5.82, 0.00)